pharmaphorum
MAY 10, 2022
Roche has elevated a longstanding alliance with Finland’s Kaiku Health focusing on digital patient monitoring and management (DPMM) to the level of a strategic partnership. The two companies have been working together since 2019 on digital health interventions to provide support to people with cancer, focusing initially on tools for patients undergoing cancer immunotherapy.
Outsourcing Pharma
MAY 12, 2022
The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 10, 2022
NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
Pharma Mirror
MAY 13, 2022
Rockville, Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th. The cloud platform of Advantage eClinical will be available as a standalone software product after undergoing more than two years of development.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 9, 2022
Mental health issues among teens and young adults have risen dramatically over the past decade. Jessica Lake, chief science officer at Limbix, tells us about SparkRx, a digital therapeutics app aimed to help treat adolescent depression. . SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols.
Outsourcing Pharma
MAY 9, 2022
The thin-film freezing specialist reports positive safety and pharmacokinetic data coming out of the Phase I trial of its niclosamide inhalation powder.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Marketing Network
MAY 13, 2022
WOTY stands for Woman of the Year. I am excited to share a little bit about what the Healthcare Businesswomen’s Association’s WOTY event of 2022 is and my personal experience. Words that come to mind: #Inspirational #Aspiration and #Community. This was my first WOTY and my first in person event in 2 years! I bought a new dress and shoes (which killed my feet and ended up carrying around in a reusable bag!
pharmaphorum
MAY 10, 2022
Researchers in the US have developed a wearable monitor that could be used to monitor metabolic diseases through gases released from a person’s skin. It’s a spin on the use of monitors that detect chemicals in sweat using electrical signals and has the key advantage that it does not need substantial amounts of sweat to get a reading, according to the team from Ohio State University.
Outsourcing Pharma
MAY 12, 2022
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
Compounding Pharmacy of America
MAY 11, 2022
Maintaining excellent health is one of the most crucial components of fertility for every woman. That means that one of the best ways to boost your fertility may be by ensuring your hormones, vitamins, and nutrients are at optimal levels. The post The Top Vitamins and Supplements for Fertility appeared first on The Compounding Pharmacy of America.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
NF2 BioSolutions
MAY 11, 2022
I’m Grace and I am one of the two NF2 BioSolutions UK PhD students at the University of Manchester. I am currently looking at the body’s immune cells that can invade into NF2 brain tumours which may provide new ideas that could lead to the development of targeted drugs for those with NF2. This is the goal of my 3-year PhD, but I thought I would break that down into my day-to-day routine in this ‘Day in the Life’ blog post.
pharmaphorum
MAY 9, 2022
A study has shown that a mobile game can be used to gather symptom data from children undergoing treatment for cancer, and potentially might also be used to provide personalised management of their care. That is the conclusion of a small US study looking at the role of Color Me Healthy, a gaming app developed through a collaboration between children, game designers and clinical staff.
Roots Analysis
MAY 11, 2022
Over the years, the drug hunters have tried to target the tens of thousands of proteins responsible for sickness and health. But a vast majority of them have remained out of reach. While, the scientific evolution has led to the development of potent and selective small-molecule inhibitors of protein function, but still, multiple targets of high biomedical relevance are highly challenging targets for typical small-molecule drugs.
Pharma Marketing Network
MAY 11, 2022
Data is everywhere. A few years ago, our meetings were about content and execution. Now, we find ourselves in more and more metric meetings and KPI crash sessions. The flood of information is fun, exciting, and an immense help in building world class campaigns. However, it is easy to lose sight of data fundamentals as our dashboards become prettier and the insights more granular.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
MAY 10, 2022
The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.
pharmaphorum
MAY 13, 2022
When it comes to enthusiasm about digital innovation, pharma seems to be more adept at talking the talk than walking the walk, as it were. That’s according to recent survey data from digital agency Graphite. Working with Reuters Events, the agency surveyed 450 healthcare executives, 85% of whom worked in pharma. A full 92% of the survey respondents agreed with the statement “Pharma-sponsored digital products can add value to the healthcare provider and patient by supporting the overall customer
Pharma Times
MAY 12, 2022
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
The Luxe Pharmacist
MAY 8, 2022
As the weather gets nicer and so many of us are transitioning into new roles or heading off on rotations I figured now was the perfect time for a work shoes roundup post! I lived in a handful of favorite work shoes during rotations as an APPE student and have since added more favorites to the list. I’ll include any sizing recommendations with each shoe style if it differs from my usual 6.5!
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
MAY 10, 2022
The clinical trial tech firm has announced a $220m Series D funding round which will boost its efforts to improve inclusivity and representation in studies.
pharmaphorum
MAY 10, 2022
Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing world of digital communication. But healthcare communicators have an extra layer of challenges as the conveyors of serious, important information that can also have a high degree of scientific complexity. “Healthcare can be incredibly complex.
Board Vitals - Pharmacist
MAY 7, 2022
Almost a year ago now, I became a new mom. Becoming a mom has been transformative, eye opening, beautiful, and of course, a major shock to the system. I did not come from a family with many children or emphasis on children. So, when I brought my son home from the hospital, I barely knew how to change his diaper and my anxiety skyrocketed. Next to learning how to breastfeed, counting down the short time until I went back to work was my greatest stressor.
Pharma Mirror
MAY 7, 2022
Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.
Outsourcing Pharma
MAY 10, 2022
The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.
pharmaphorum
MAY 13, 2022
Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter’s once-daily oral therapy Ryeqo, after NICE backed the GnRH antagonist to treat heavy menstrual bleeding associated with uterine fibroids. Ryeqo (relugolix/estradiol/norethisterone acetate) – originally developed by Myovant – is the first drug in the class to be approved for NHS use in this indication, offering another option to treatment with injectable GnRH drugs used for women with moderate to severe symptom
Pharma Times
MAY 13, 2022
Data shows that 1.
Med Ed 101
MAY 11, 2022
I don’t take a break from clinical content very often, but when I do, it’s usually something that is very important to me personally. Every day, I try to think about what might help a fellow healthcare professional use medications more wisely. I’ve been blogging since 2013 and podcasting (Real Life Pharmacology) since 2018. Hitting […].
Outsourcing Pharma
MAY 9, 2022
Illumina has recently announced a 10-year-long strategic collaboration with Janssen Biotech, and a five-year partnership with Deerfield Management.
pharmaphorum
MAY 12, 2022
AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that it can achieve clinical remission over a full year when used as a maintenance therapy. The results of the U-ENDURE study bolster the clinical case for Rinvoq (upadacitinib), which is trying to become the first drug in the JAK inhibitor class to be approved by the FDA for Crohn’s disease with a filing due this year.
Pharma Times
MAY 12, 2022
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
Pharma Mirror
MAY 11, 2022
Abzena, the leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs) has announced the appointment of Dr. Petra Dieterich, DPhil, MBA, as scientific lead. Reporting to Abzena’s chief technology officer Dr. Louise Duffy, Dr. Dieterich will use her extensive technical knowledge and leadership experience to support Abzena’s successful drug development and manufacturing operations, ultimately assisting
Med Ed 101
MAY 8, 2022
There are many skeletal muscle relaxants (SMRs) to choose from when patients need one. We are going to do some comparing and contrasting of these medications, and ultimately, this article will help you identify some of the most important clinical factors to consider when selecting a skeletal muscle relaxant. For your reference, our friends at […].
pharmaphorum
MAY 9, 2022
Adding Nykode Therapeutics’ VB10.16 vaccine to treatment with Roche’s cancer immunotherapy Tecentriq resulted in disease control in two-thirds of patients with advanced cervical cancer. The combination of vaccine and checkpoint inhibitor had an overall response rate of 21% in the phase 2 VB C-02 trial involving 39 patients with HPV16-positive cervical cancer, including two complete responses and six partial responses with six months follow-up, said the Norwegian biotech.
Pharma Times
MAY 11, 2022
The project will analyse risks from Sano Genetics’ data from 3,000 UK adults suffering from long COVID
Expert insights. Personalized for you.
137 
Let's personalize your content